75 related articles for article (PubMed ID: 9367887)
1. Upregulation of the anti-apoptotic protein Bcl-2 may be an early event in neurodegeneration: studies on Parkinson's and incidental Lewy body disease.
Marshall KA; Daniel SE; Cairns N; Jenner P; Halliwell B
Biochem Biophys Res Commun; 1997 Nov; 240(1):84-7. PubMed ID: 9367887
[TBL] [Abstract][Full Text] [Related]
2. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease.
Dickson DW; Fujishiro H; DelleDonne A; Menke J; Ahmed Z; Klos KJ; Josephs KA; Frigerio R; Burnett M; Parisi JE; Ahlskog JE
Acta Neuropathol; 2008 Apr; 115(4):437-44. PubMed ID: 18264713
[TBL] [Abstract][Full Text] [Related]
3. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
4. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease.
Dexter DT; Sian J; Rose S; Hindmarsh JG; Mann VM; Cooper JM; Wells FR; Daniel SE; Lees AJ; Schapira AH
Ann Neurol; 1994 Jan; 35(1):38-44. PubMed ID: 8285590
[TBL] [Abstract][Full Text] [Related]
5. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
[TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
7. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
8. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease.
Banati RB; Daniel SE; Blunt SB
Mov Disord; 1998 Mar; 13(2):221-7. PubMed ID: 9539333
[TBL] [Abstract][Full Text] [Related]
9. [Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].
Wakabayashi K; Takahashi H; Oyanagi K; Ikuta F
No To Shinkei; 1993 Nov; 45(11):1033-8. PubMed ID: 8135950
[TBL] [Abstract][Full Text] [Related]
10. Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease.
Tatton NA
Exp Neurol; 2000 Nov; 166(1):29-43. PubMed ID: 11031081
[TBL] [Abstract][Full Text] [Related]
11. Neurodegeneration in normal brain aging and disease.
Thal DR; Del Tredici K; Braak H
Sci Aging Knowledge Environ; 2004 Jun; 2004(23):pe26. PubMed ID: 15190177
[TBL] [Abstract][Full Text] [Related]
12. G protein-coupled receptor kinase 5, overexpressed in the alpha-synuclein up-regulation model of Parkinson's disease, regulates bcl-2 expression.
Liu P; Wang X; Gao N; Zhu H; Dai X; Xu Y; Ma C; Huang L; Liu Y; Qin C
Brain Res; 2010 Jan; 1307():134-41. PubMed ID: 19852948
[TBL] [Abstract][Full Text] [Related]
13. Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia.
Trojanowski JQ; Goedert M; Iwatsubo T; Lee VM
Cell Death Differ; 1998 Oct; 5(10):832-7. PubMed ID: 10203692
[TBL] [Abstract][Full Text] [Related]
14. bcl-2 protein is increased in the brain from parkinsonian patients.
Mogi M; Harada M; Kondo T; Mizuno Y; Narabayashi H; Riederer P; Nagatsu T
Neurosci Lett; 1996 Sep; 215(2):137-9. PubMed ID: 8888015
[TBL] [Abstract][Full Text] [Related]
15. Presymptomatic detection of Parkinson's disease.
Jenner P
J Neural Transm Suppl; 1993; 40():23-36. PubMed ID: 8294898
[TBL] [Abstract][Full Text] [Related]
16. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
Youdim MB; Fridkin M; Zheng H
Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
[TBL] [Abstract][Full Text] [Related]
17. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
18. alpha-Synucleinopathy in the human olfactory system in Parkinson's disease: involvement of calcium-binding protein- and substance P-positive cells.
Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Argandoña-Palacios L; Garcia-Muñozguren S; Martinez-Marcos A
Acta Neuropathol; 2010 Jun; 119(6):723-35. PubMed ID: 20383714
[TBL] [Abstract][Full Text] [Related]
19. Olfactory system pathology as a model of Lewy neurodegenerative disease.
Duda JE
J Neurol Sci; 2010 Feb; 289(1-2):49-54. PubMed ID: 19783257
[TBL] [Abstract][Full Text] [Related]
20. Free radicals in Parkinson's disease.
Koutsilieri E; Scheller C; Grünblatt E; Nara K; Li J; Riederer P
J Neurol; 2002 Sep; 249 Suppl 2():II1-5. PubMed ID: 12375056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
